IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases

by | May 6, 2026 | Clinical Trials | 0 comments

​ Conditions: Brain Metastases

Interventions: Biological: Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells

Sponsors: University of Florida

Not yet recruiting Conditions: Brain Metastases
Interventions: Biological: Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
Sponsors: University of Florida
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *